IP – licensed from Duke and NCSU, multiple filings in 4 patent areas, 10+ issued patents
Grants/Awards: $4.6M (MedBlue, DTRI, NCBiotech TEG and SRL, NIH STTR Phase I, NIH SBIR Phase I & II).
Private financing closed in 2019 and 2022
FDA 510(k) Clearances for T-Line Hernia Mesh 2020 and 2022
Four additional products in development for full abdominal wall surgery portfolio

Deep Blue is developing a novel hernia mesh to address the unacceptably high rate of hernia occurrence and recurrence.

At A Glance

Deep Blue Overview